Vordenberg Sarah E, Maitah Yehya, Khan Zaid, DeBacker Ken, Dorsch Michael P
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):135-143. doi: 10.1016/j.japh.2022.09.008. Epub 2022 Sep 18.
There are more than 300,000 over-the-counter (OTC) medications on the market making it challenging for consumers to select safe and effective products to treat their minor ailments.
We sought to identify consumer perceptions about the use of a clinical decision support system, OTC Coach, to help them make informed decisions about OTC medications.
We developed a prototype of the OTC Coach that focused on treating fever in adults. We recruited community members who were 18 years and older via our institutional research website. Participants completed a 30- to 45-minute video interview in which they initially discussed their perceptions and experiences of using OTC medications. We subsequently shared the OTC Coach prototype and sought feedback related to the content and format of the tool. We asked participants to rate their likelihood of using the tool to treat a new symptom (10-point Likert scale, 1 = not at all to 10 = extremely likely) and conducted a qualitative and quantitative analysis of these findings.
Among 20 participants, 11 (55%) were female, 10 (50%) were white, and the mean age was 47.9 years (range 18-81 years). Participants reported that the tool was easy to understand. The questions reported as being extremely important by most participants were allergies (n = 17, 85%), increased risk of bleeding (n = 15, 75%), temperature (n = 12, 60%), and duration of symptoms (n = 12, 60%). Three-fourths of participants (n = 15) selected a score of 7 or higher when asked about their likelihood of using this tool for a new symptom. Concerns that were raised included ensuring that the tool accounted for their personal health history, data storage, and accessibility.
Consumers were interested in using an electronic tool to determine if their symptoms can be self-treated and, if so, which medications are appropriate.
市场上有超过30万种非处方(OTC)药物,这使得消费者难以选择安全有效的产品来治疗小病小痛。
我们试图确定消费者对使用临床决策支持系统“OTC教练”的看法,以帮助他们就非处方药物做出明智的决策。
我们开发了一个专注于治疗成人发烧的“OTC教练”原型。我们通过机构研究网站招募了18岁及以上的社区成员。参与者完成了一次30至45分钟的视频访谈,他们首先讨论了使用非处方药物的看法和经历。随后,我们分享了“OTC教练”原型,并寻求与该工具的内容和形式相关的反馈。我们要求参与者对使用该工具治疗新症状的可能性进行评分(10分制李克特量表,1 = 完全不可能至10 = 极有可能),并对这些结果进行定性和定量分析。
20名参与者中,11名(55%)为女性,10名(50%)为白人,平均年龄为47.9岁(范围18 - 81岁)。参与者表示该工具易于理解。大多数参与者认为极其重要的问题是过敏(n = 17,85%)、出血风险增加(n = 15,75%)、体温(n = 12,60%)和症状持续时间(n = 12,60%)。四分之三的参与者(n = 15)在被问及使用该工具治疗新症状的可能性时选择了7分或更高的分数。提出的担忧包括确保该工具考虑到他们的个人健康史、数据存储和可及性。
消费者有兴趣使用电子工具来确定他们的症状是否可以自我治疗,如果可以,哪些药物是合适的。